You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

COVID-19: Obtenez les dernières mises à jour ou faites une autoévaluation.

Funding & Reimbursement

Several payment sources exist for cancer drugs in Ontario, depending on the drug, disease indication, and how and where it is delivered. Cancer drugs may be covered by public funding programs, hospitals or by private pay through either insurance coverage or patient out-of-pocket costs.

The Ministry of Health and Long-Term Care is responsible for drug funding decisions, while Cancer Care Ontario oversees the reimbursement process based on those funding decisions.